Is small smarter? Nanomaterial-based detection and elimination of circulating tumor cells: current knowledge and perspectives

Alena Gribko,1 Julian Künzel,1 Désirée Wünsch,1 Qiang Lu,1 Sophie Madeleine Nagel,1 Shirley K Knauer,2 Roland H Stauber,1 Guo-Bin Ding1,3 1Nanobiomedicine Department/ENT, University Medical Center Mainz, Mainz 55131, Germany; 2Department of Molecular Biology...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Gribko A, Künzel J, Wünsch D, Lu Q, Nagel SM, Knauer SK, Stauber RH, Ding GB
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2019
Materias:	liquid biopsy cancer biomarker metastasis nanomedicine nanotherapy therapy resistance Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/496cd4ae1da747aeb468be157fb4a704
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:496cd4ae1da747aeb468be157fb4a704
record_format	dspace
spelling	oai:doaj.org-article:496cd4ae1da747aeb468be157fb4a7042021-12-02T05:51:13ZIs small smarter? Nanomaterial-based detection and elimination of circulating tumor cells: current knowledge and perspectives1178-2013https://doaj.org/article/496cd4ae1da747aeb468be157fb4a7042019-06-01T00:00:00Zhttps://www.dovepress.com/is-small-smarter-nanomaterial-based-detection-and-elimination-of-circu-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Alena Gribko,1 Julian Künzel,1 Désirée Wünsch,1 Qiang Lu,1 Sophie Madeleine Nagel,1 Shirley K Knauer,2 Roland H Stauber,1 Guo-Bin Ding1,3 1Nanobiomedicine Department/ENT, University Medical Center Mainz, Mainz 55131, Germany; 2Department of Molecular Biology II, Center for Medical Biotechnology (ZMB)/Center for Nanointegration (CENIDE), University Duisburg-Essen, Essen 45117, Germany; 3Institute of Biotechnology, Key Laboratory of Chemical Biology and Molecular Engineering of Ministry of Education, Shanxi University, Taiyuan 030006, People’s Republic of China Abstract: Circulating tumor cells (CTCs) are disseminated cancer cells. The occurrence and circulation of CTCs seem key for metastasis, still the major cause of cancer-associated deaths. As such, CTCs are investigated as predictive biomarkers. However, due to their rarity and heterogeneous biology, CTCs’ practical use has not made it into the clinical routine. Clearly, methods for the effective isolation and reliable detection of CTCs are urgently needed. With the development of nanotechnology, various nanosystems for CTC isolation and enrichment and CTC-targeted cancer therapy have been designed. Here, we summarize the relationship between CTCs and tumor metastasis, and describe CTCs’ unique properties hampering their effective enrichment. We comment on nanotechnology-based systems for CTC isolation and recent achievements in microfluidics and lab-on-a-chip technologies. We discuss recent advances in CTC-targeted cancer therapy exploiting the unique properties of nanomaterials. We conclude by introducing developments in CTC-directed nanosystems and other advanced technologies currently in (pre)clinical research. Keywords: liquid biopsy, cancer biomarker, metastasis, nanomedicine, nanotherapy, therapy resistanceGribko AKünzel JWünsch DLu QNagel SMKnauer SKStauber RHDing GBDove Medical Pressarticleliquid biopsycancer biomarkermetastasisnanomedicinenanotherapytherapy resistanceMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 14, Pp 4187-4209 (2019)
institution	DOAJ
collection	DOAJ
language	EN
topic	liquid biopsy cancer biomarker metastasis nanomedicine nanotherapy therapy resistance Medicine (General) R5-920
spellingShingle	liquid biopsy cancer biomarker metastasis nanomedicine nanotherapy therapy resistance Medicine (General) R5-920 Gribko A Künzel J Wünsch D Lu Q Nagel SM Knauer SK Stauber RH Ding GB Is small smarter? Nanomaterial-based detection and elimination of circulating tumor cells: current knowledge and perspectives
description	Alena Gribko,1 Julian Künzel,1 Désirée Wünsch,1 Qiang Lu,1 Sophie Madeleine Nagel,1 Shirley K Knauer,2 Roland H Stauber,1 Guo-Bin Ding1,3 1Nanobiomedicine Department/ENT, University Medical Center Mainz, Mainz 55131, Germany; 2Department of Molecular Biology II, Center for Medical Biotechnology (ZMB)/Center for Nanointegration (CENIDE), University Duisburg-Essen, Essen 45117, Germany; 3Institute of Biotechnology, Key Laboratory of Chemical Biology and Molecular Engineering of Ministry of Education, Shanxi University, Taiyuan 030006, People’s Republic of China Abstract: Circulating tumor cells (CTCs) are disseminated cancer cells. The occurrence and circulation of CTCs seem key for metastasis, still the major cause of cancer-associated deaths. As such, CTCs are investigated as predictive biomarkers. However, due to their rarity and heterogeneous biology, CTCs’ practical use has not made it into the clinical routine. Clearly, methods for the effective isolation and reliable detection of CTCs are urgently needed. With the development of nanotechnology, various nanosystems for CTC isolation and enrichment and CTC-targeted cancer therapy have been designed. Here, we summarize the relationship between CTCs and tumor metastasis, and describe CTCs’ unique properties hampering their effective enrichment. We comment on nanotechnology-based systems for CTC isolation and recent achievements in microfluidics and lab-on-a-chip technologies. We discuss recent advances in CTC-targeted cancer therapy exploiting the unique properties of nanomaterials. We conclude by introducing developments in CTC-directed nanosystems and other advanced technologies currently in (pre)clinical research. Keywords: liquid biopsy, cancer biomarker, metastasis, nanomedicine, nanotherapy, therapy resistance
format	article
author	Gribko A Künzel J Wünsch D Lu Q Nagel SM Knauer SK Stauber RH Ding GB
author_facet	Gribko A Künzel J Wünsch D Lu Q Nagel SM Knauer SK Stauber RH Ding GB
author_sort	Gribko A
title	Is small smarter? Nanomaterial-based detection and elimination of circulating tumor cells: current knowledge and perspectives
title_short	Is small smarter? Nanomaterial-based detection and elimination of circulating tumor cells: current knowledge and perspectives
title_full	Is small smarter? Nanomaterial-based detection and elimination of circulating tumor cells: current knowledge and perspectives
title_fullStr	Is small smarter? Nanomaterial-based detection and elimination of circulating tumor cells: current knowledge and perspectives
title_full_unstemmed	Is small smarter? Nanomaterial-based detection and elimination of circulating tumor cells: current knowledge and perspectives
title_sort	is small smarter? nanomaterial-based detection and elimination of circulating tumor cells: current knowledge and perspectives
publisher	Dove Medical Press
publishDate	2019
url	https://doaj.org/article/496cd4ae1da747aeb468be157fb4a704
work_keys_str_mv	AT gribkoa issmallsmarternanomaterialbaseddetectionandeliminationofcirculatingtumorcellscurrentknowledgeandperspectives AT kunzelj issmallsmarternanomaterialbaseddetectionandeliminationofcirculatingtumorcellscurrentknowledgeandperspectives AT wunschd issmallsmarternanomaterialbaseddetectionandeliminationofcirculatingtumorcellscurrentknowledgeandperspectives AT luq issmallsmarternanomaterialbaseddetectionandeliminationofcirculatingtumorcellscurrentknowledgeandperspectives AT nagelsm issmallsmarternanomaterialbaseddetectionandeliminationofcirculatingtumorcellscurrentknowledgeandperspectives AT knauersk issmallsmarternanomaterialbaseddetectionandeliminationofcirculatingtumorcellscurrentknowledgeandperspectives AT stauberrh issmallsmarternanomaterialbaseddetectionandeliminationofcirculatingtumorcellscurrentknowledgeandperspectives AT dinggb issmallsmarternanomaterialbaseddetectionandeliminationofcirculatingtumorcellscurrentknowledgeandperspectives
_version_	1718400169168338944

Is small smarter? Nanomaterial-based detection and elimination of circulating tumor cells: current knowledge and perspectives

Ejemplares similares